Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11 XW013TB
ICD-10-PCS code XW013TB for Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11 is a medical classification as listed by CMS under Anatomical Regions range.
ICD-10-PCS Code Symbols
: NewOfficial Code Descriptor
Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11
Crosswalks
Tabs
No record found
Crosswalk an ICD-10-PCS code to CPT®
Additional/Related Information
Tabs
| Section(X) | Body System(W) | Operation(0) | Body Part(1) | Approach(3) | Device / Substance / Technology(T) | Qualifier(B) |
| New Technology | Anatomical Regions | Introduction | Subcutaneous Tissue | Percutaneous | Rozanolixizumab-noli Monoclonal Antibody | New Technology Group 11 |
No record found
| Change Type | Change Date | Previous Descriptor |
| Code Added | 10-01-2025 |
No need to flip from a code to the front of a book or to hunt through online PDFs to locate applicable chapter and block specific guidelines. See essential instructions from ICD-10-PCS Official Guidelines for Coding and Reporting right on your code details page.
